Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

SGMOQ holding history

Sangamo Therapeutics, Inc in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of SGMOQ by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−14,840−100.0%Sold outHolders
Q1 202614,840$3.66K<0.1%+1,990+15.5%AddedHolders
Q4 202512,850$5.40K<0.1%+50+0.4%AddedHolders
Q3 202512,800$8.62K<0.1%+2,800+28.0%AddedHolders
Q2 202510,000$5.41K<0.1%−8,985−47.3%ReducedHolders
Q1 202518,985$12.4K<0.1%−679−3.5%ReducedHolders
Q4 202419,664$20.1K<0.1%+679+3.6%AddedHolders
Q3 202418,985$16.4K<0.1%+5,000+35.8%AddedHolders
Q2 202413,985$5.01K<0.1%+295+2.2%AddedHolders
Q1 202413,690$9.18K<0.1%00.0%UnchangedHolders
Q4 202313,690$7.44K<0.1%00.0%UnchangedHolders
Q3 202313,690$8.21K<0.1%−1,000−6.8%ReducedHolders
Q2 202314,690$19.1K<0.1%−15,518−51.4%ReducedHolders
Q1 202330,208$53.2K<0.1%+14,168+88.3%AddedHolders
Q4 202216,040$50.4K<0.1%+1,061+7.1%AddedHolders
Q3 202214,979$73.0K<0.1%+139+0.9%AddedHolders
Q2 202214,840$61.0K<0.1%00.0%UnchangedHolders
Q1 202214,840$86.0K<0.1%−1,429−8.8%ReducedHolders
Q4 202116,269$122.0K<0.1%+679+4.4%AddedHolders
Q3 202115,590$140.0K<0.1%+1,900+13.9%AddedHolders
Q2 202113,690$164.0K<0.1%−2,130−13.5%ReducedHolders
Q1 202115,820$198.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.